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Abstract
Background and methods: Pseudomonas aeruginosa is a major infectious threat to immunocompromised
patients. We recently reported a fatal epidemic of multidrug-resistant P. aeruginosa in an onchoematology unit,
linked to massive contamination of a triclosan-based disinfectant. The aim of this study is to evaluate the
antimicrobial activity of triclosan and chlorhexidine digluconate against the epidemic strain of P. aeruginosa,t o
confirm the hypothesis that the soap dispenser acted as a continuous source of the infection during the outbreak,
and to explore the potential role of triclosan in increasing the level of resistance to selected antibiotics.
Susceptibility tests and time-kill assays for disinfectans were performed using two commercial formulations
containing triclosan and chlorhexidine digluconate, respectively. Antibiotic susceptibility testing was performed by
the broth microdilution method.
Findings: The P. aeruginosa epidemic strain exhibited an extremely high level of triclosan resistance (apparent MIC
= 2,125 mg/L), while it was markedly susceptible to chlorhexidine digluconate (apparent MIC = 12.5 mg/L). Upon
gradual adaptation to triclosan, the epidemic strain survived for a long period (> 120 h) in the presence of 3,400
mg/L (equivalent to 1.6 × MIC) of triclosan, concomitantly increasing the resistance to six antibiotics that are typical
substrates of drug efflux pumps of the resistance nodulation division family. This effect was reversed by efflux
pump inhibitors.
Conclusions: The epidemic P. aeruginosa strain was resistant to triclosan and its previous exposure to triclosan
increases antibiotic resistance, likely through active efflux mechanisms. Since P. aeruginosa can become tolerant to
elevated triclosan concentrations, the use of triclosan-based disinfectants should be avoided in those healthcare
settings hosting patients at high risk for P. aeruginosa infection.
Background
The Gram-negative, rod shaped, aerobic bacterium
Pseudomonas aeruginosa i sal e a d i n gc a u s eo fs e v e r e
infections in hospitalized subjects [1]. Colonization of
the hospital environment, which may also involve
antiseptic solutions, is a well-established mechanisms
of P. aeruginosa persistence and spread in healthcare
setting [2,3].
We recently described an outbreak of multidrug-resis-
tant (MDR) P. aeruginosa infection which occurred in a
oncohematology unit in Italy [3]. The outbreak involved
5 patients, 3 of whom died. Isolates from all 5 cases of
infection showed an identical antibiotic resistance pat-
tern (i.e. resistant to fluoroquinolones and aminoglyco-
sides and susceptible to beta-lactams), all belonged to
sequence type 175, and showed identical pulsotype and
RAPD type, forming a single epidemiological cluster.
We were also able to trace back the source of infection
to a common soap dispenser which was found to be
heavily contaminated with the same P. aeruginosa iso-
lates infecting the cases. This soap dispenser used to be
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4% clorexidine digluconate or 0.5% triclosan in 3
months rotation; at the time infections set in, the dis-
penser contained the triclosan soap.
Triclosan is an antiseptics commonly used in hospitals
because of the broad antimicrobial activity [4]. However,
concern has been raised over triclosan efficacy since
some bacterial species are endowed with intrinsic resis-
tance to this compound [4]. P. aeruginosa is resistant to
triclosan as the consequence of the expression of multi-
ple mechanisms, including active efflux from the cells
mediated by the resistance nodulation division (RND)
family of efflux pumps [5], the presence of a triclosan-
resistant enoyl-acyl carrier protein reductase (FabV) [6],
outer membrane impermeability, and the expression of
a triclosan-specific pump (TriABC-OpmH) [7,8]. Some
of these mechanisms are also associated with the devel-
opment of resistance to some clinically significant anti-
biotics, raising the additional concern that, under
certain circumstances, inappropriate use of triclosan-
containing disinfectants may select for resistance against
clinically useful drugs [9,10]. The aim of this study was
to evaluate the activity of two commercial disinfectants
containing triclosan and chlorhexidine digluconate
against the epidemic P. aeruginosa strain, in order to
confirm the hypothesis that the soap dispenser contain-
ing triclosan may have actually acted as a continuous
source of the infection during the outbreak [3], and to
explore the potential role played by triclosan in enhan-
cing the level of resistance to selected antibiotics.
Methods
Bacterial isolates
Six different P. aeruginosa strains were isolated through-
out the outbreak investigation, as previously reported
[3]. P. aeruginosa strain L2 was isolated in the triclosan-
containing soap dispenser and isolates L3 and L4 from
water outlets in patients rooms (environmental isolates).
P. aeruginosa isolates 10, 11 and 13 were isolated from
patients’ biological specimens (clinical isolates). Isolates
L2, 10, 11 and 13 all belonged to sequence type 175 and
were indistinguishable by pulsotyping, RAPD and MLST
analysis, while isolates L3 and L4 showed a distinct type
[3]. After primary isolation, isolates were sub-cultured
for 4-6 times in Mueller-Hinton (MH, Oxoid, Milan,
Italy) agar, and then stored frozen in MH broth.
Disinfectants
Two commercial disinfectants were used in this study,
designated product A and product B, whose composition
(% w/v in water) is: (A) 0.5% 2,4,4’-trichloro-2’-hydroxy-
diphenyl-ether (triclosan), 10% sodium lauryl-myristyl
ether sulfate, 3% coconut glycerol, 2.5%coconut amido
propyl betaine, and 1.5% alcohol ethoxylate; (B)4 %
chlorhexidine gluconate, 15% polysorbate 20, 5%
coconut diethanolamide, 4% alkyl polyglucoside, 1%
polyethylene glycol (PEG)-150, 1% isopropyl alcohol,
0.1% essence, and 0.005% E 124.
Susceptibility tests for disinfectants
Taking into account the very poor solubility of triclosan
in aqueous solutions [11], the antimicrobial susceptibil-
ity tests and the time kill assay were performed using
the commercial soap formulations. In the commercial
product A, triclosan is well soluble (it is 5,000 mg/L),
and its addition to MH broth (that was adequately con-
centrated to have a final concentration of 1 × MH broth
in all assays) did not result in any precipitation of the
disinfectant.
P. aeruginosa was grown to the early stationary phase
in MH broth. Bacterial cultures were diluted to 0.5
MacFarland turbidity in MH broth (~5 × 10
8 CFU/ml).
This suspension was diluted 1:10 (~5 × 10
7 CF/mL) in
MH broth, and 10 μl were used as inoculum in 96-well
microtiter plates (Costar, Cambridge, Massachusetts)
containing 190 μl of serial two-fold dilutions of the dis-
infectant soaps in 1 × MH broth. To test the highest
concentration of triclosan (4,250 mg/L, which corre-
sponds to the minimum soap dilution), 20 μl of 10 × con-
centrated MH broth were mixed with 170 μl of undiluted
triclosan soap (product A) containing 5,000 mg/L triclo-
san and 10 μl of bacterial inoculum (~2.5 × 10
6). All
other dilutions were prepared by combining appropri-
ate volumes of 10 × concentrated MH broth, triclosan
soap, sterile water, and the standard 10-μl bacterial
inoculum.
To test the susceptibility of P. aeruginosa to chlorexi-
dine digluconate (product B), standard two-fold dilutions
of the disinfectant were generated in 1 × MH broth and
inoculated with ~2.5 × 10
6 CFU/mL in 96-well microti-
ter plates (Costar).
Since the disinfectant soaps were commercial mixtures
of triclosan or chlorhexidine with other ingredients
which may or may not be inert, the observed minimal
inhibitory concentrations (MICs) were called “apparent
MICs” (a-MICs). The a-MIC was expressed as the mini-
mal concentration of the disinfectant in the commercial
formulation causing no growth after 48-h incubation at
37°C [12,13], with chlorhexidine > 50 mg/L [14] and tri-
closan > 128 mg/L [13] as resistance breakpoints. Each
experiment was performed in triplicate.
Determination of the bactericidal activity for disinfectants
P. aeruginosa L2 suspensions (~5 × 10
7 CFU/mL) were
made in MH broth supplemented with either product
A (triclosan range: 1,062-4,250 mg/L) or product B
(chlorhexidine digluconate range: 12.5-1,250 mg/L),
and incubated at 37°C. The two products were diluted
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tion in order to compensate for the addition of an
appropriate volume of disinfectant and a constant bac-
terial inoculum. At defined intervals, aliquots were
neutralized by rapid serial dilution in MH broth sup-
plemented with 0.5% lecithin and 4% polysorbate 20
[15], plated on MH agar plates, and examined after 24-
h incubation at 37°C for determination of viable
counts.
Adaptation to high triclosan concentration
The frozen stock of P. aeruginosa L2 was readapted to
triclosan by passages in gradually increasing triclosan
concentrations. Inocula of ~5 × 10
5 CFU/mL were seri-
ally cultured in stepwise increasing triclosan concentra-
tions in MH broth at 37°C, starting with 1/2 the MIC
and doubling the concentration at each passage until
evidence of full growth.
Antimicrobial susceptibility testing
The susceptibility of triclosan-adapted and unadapted P.
aeruginosa to a panel of antibiotics which are typically
exported by RND efflux pumps [16], namely tetracy-
cline, ciprofloxacin, amikacin, levofloxacin, carbenicillin
and chloramphenicol (all from Sigma-Aldrich) was
determined by the broth microdilution method accord-
ing to the CLSI guidelines [12] either with or without
the RND efflux pump inhibitor phenyl-arginine-b-
naphthylamide (PAbN) or the protonophore carbonyl
cyanide m-chlorophenylhydrazone (CCCP) (Sigma-
Aldrich) at the predetermined concentrations of 50 μM
and 100 μM, respectively. Each experiment was per-
formed in triplicate.
Results
Susceptibility to triclosan and chlorhexidine digluconate
Elevated triclosan resistance (a-MIC = 2,125 mg/L for
isolates 10, 11, 13 and L2; a-MIC = 4,250 mg/L for iso-
lates L3 and L4) was observed for both clinical and
environmental P. aeruginosa isolates tested after primary
isolation and serial passages in MH broth. Conversely,
all isolates were markedly susceptible to chlorhexidine
digluconate (a-MIC = 12.5 mg/L).
Determination of the bactericidal activity for disinfectants
Time-kill kinetics of the two disinfectants were deter-
mined for the P. aeruginosa L2 soap isolate, regarded to
as the prototypic epidemic strain.
Chlorhexidine digluconate at ≥ 125 mg/L exerted a
rapid bactericidal effect (> 3 log10 reduction of viable
counts) within 5 min of contact with P. aeruginosa L2
cells. This concentration is far below the actual concen-
tration, 40,000 mg/L, provided by the manufacturer in
the commercial product B (Figure 1, upper panel).
The triclosan-containing product A was much less
effective in killing P. aeruginosa L2 cells (Figure 1,
lower panel). Only the highest triclosan concentration
achievable in MH broth (4,250 mg/L, equivalent to 2 ×
MIC) exerted strong bactericidal activity within 3 h of
contact with P. aeruginosa cells (> 6 log10 reduction of
CFU/ml). When exposed to triclosan concentrations of
1,6 × MIC (3,400 mg/L), L2 cells were killed during
the initial 6 h (> 3 log10 reduction of CFU/ml), but the
residual population could then survive for a long per-
iod (> 120 h) in the presence of this concentration of
the disinfectant. At triclosan concentration of 2,125
and 1,062 mg/L (equivalent to 1× and 0,5 × MIC,
respectively) ~1 log10 reduction of cell viability was
observed relative to the inoculum size at 24 h, but
afterwards growth was restored and the bacterial popu-
lation reached the same density as the control in tri-
closan-free medium after 120 h.
Adaptation to triclosan results in increased levels of
antibiotic resistance
In P. aeruginosa, triclosan resistance is mediated at least
by 4 efflux pumps, belonging to the RND family
(MexAB-OprM, MexCD-OprJ, MexEF-OprN, and
MexXY-OprM), which can also drive active extrusion of
various antibiotics [5,10]. Therefore, we tested the sus-
ceptibility to six antibiotics (tetracycline, ciprofloxacin,
amikacin, levofloxacin carbenicillin and chlorampheni-
col) typically exported via RND pumps in unadapted
and triclosan-adapted P. aeruginosa L2 cells (Table 1).
We observed that the efflux pump inhibitors PAbNo r
CCCP, at concentrations which do not affect bacterial
growth, decreased the MIC of tetracycline, ciprofloxacin,
amikacin, levofloxacin, carbenicillin and chlorampheni-
col by a factor 2-4 in triclosan-unadapted P. aeruginosa
cells. Remarkably, adaptation of P. aeruginosa L2 to
sub-lethal concentrations of triclosan (up to 3,400 mg/L,
see Methods and Table 1) resulted in a 2-fold increase
of MICs for all six antibiotics. Efflux pump inhibitors
(PAbN or CCCP) restored antibiotic susceptibility of the
triclosan-adapted isolate to the same or even higher
level than the unadapted isolate (2-4 fold reduction of
MICs, Table 1), suggesting that active antibiotic efflux
was enhanced in P. aeruginosa cells following triclosan
exposure.
Discussion
A P. aeruginosa strain, which eventually caused a fatal
epidemic cluster, was able to contaminate and likely
replicate within a triclosan-soap dispenser. Triclosan is
an anionic, lipophilic compound that is very poorly solu-
ble in water [11]. However, previous researchers have
reported that various solubilizers, such as the surfactant
sodium lauryl sulphate, increase the solubility of
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and the formation of either salts or complexes are pos-
tulated as possible mechanisms for the increase in the
solubility of triclosan [11]. In this study, we decided to
perform the antimicrobial susceptibility tests and the
time kill assays using the commercial soap product A,i n
which triclosan (5,000 mg/L) is kept in solution by 10%
sodium lauryl-myristyl ether sulfate. Assuming that this
Chlorhexidine digluconate 
Triclosan
Figure 1 Time-kill kinetics of P. aeruginosa L2 in MH broth supplemented with chlorhexidine digluconate (product B, upper panel) or
triclosan (product A, lower panel) at given concentrations.
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increased the effectiveness of triclosan in killing P. aeru-
ginosa, this would paradoxically imply that the actual P.
aeruginosa resistance to triclosan alone would be higher
than that observed in our experimental system.
Determination of the bactericidal activity for triclosan
confirmed that the epidemic strain could have contami-
nated the soap dispenser most probably because of its
remarkable tolerance to triclosan. In fact this epidemic
strain was originally isolated at relatively high concen-
tration (5 × 10
4 CFU/mL) from the dispenser containing
the triclosan-based commercial soap (product A)f o r
healthcare workers’ hand washing [3]. These findings
provide additional biological evidence to confirm our
previous hypothesis, based on molecular identity
between patients’ and soap P. aeruginosa isolates [3],
that the contaminated soap dispenser may have acted as
the primary source of infection. We can also suppose
that the activity of triclosan in the commercial formula-
tion was reduced by partial inactivation of triclosan by
micellar entrapping on inclusion which may have
reduced the amount of free triclosan available in
solution.
Conversely, the chlorhexidine-based disinfectant,
which was employed in rotation of 3 months with triclo-
san in the oncohematology unit [3], had strong and fast
bactericidal effect at concentrations far below those
recommended by the manufacturer for practical use.
Another interesting result was that the level of resis-
tance to some antibiotics, namely tetracycline, fluoroqui-
nolones, aminoglycosides, carbenicillin and
chloramphenicol, was increased by previous adaptation
of P. aeruginosa to triclosan. As reported in other stu-
dies [10,16], triclosan may induce the expression of mul-
tidrug efflux systems belonging to RND family in P.
aeruginosa. These systems are relatively nonspecific in
substrate recognition and enables bacteria to pump out
numerous chemically unrelated substances, such as
antibiotics and biocides. Here, we report that the pattern
of increasing resistance to antibiotics was likely to be
driven by activation of efflux pumps belonging to the
R N Df a m i l y ;i nf a c t ,t h eR N De f f l u xp u m pi n h i b i t o r
PAbN and the protonophore CCCP restored the base-
line antibiotic susceptibility in the triclosan-adapted
strain. Thus, while the link between triclosan usage and
development of clinically significant clinical resistance to
antibiotics remains controversial [9,10], here we provide
evidence that previous exposure to triclosan elevates the
level of antibiotic resistance. Although the differences in
MICs obtained for the different antibiotics are small (2-
fold), they provide a clear evidence of the overall trend
towards increasing antibiotic resistance associated with
adaptation to tricosan. Increased resistance was also
observed for those antibiotics to which P. aeruginosa L2
cells showed elevated baseline resistance. As noted for
carbenicillin, adaptation to triclosan converted the sus-
ceptible phenotype (MIC ≤ 128 mg/L) into intermediate
resistant (MIC = 256 mg/L).
To the best of our knowledge, this is the first time
that such a high tolerance to triclosan is documented in
a clinical P. aeruginosa isolate, since previous studies on
both uncharacterized and type (PAO1) P. aeruginosa
strains reported actual MICs of ~ 1,000 mg/L [17].
Some issues limit the generalizability our findings.
Firstly, our data come from a single epidemic event, and
therefore they may not apply in the same way to see-
mingly similar episodes in other institutions or to gen-
eral clinical practices as biological features of the
outbreak strain (e.g. virulence, infectivity, and/or base-
line resistance patterns) and/or local situation (e.g.
infection control policies, mode of transmission, and/or
risk factors) may be unique. Secondly, we could not
quantify the actual triclosan concentration in the triclo-
san-based commercial soap formulation - as it was in
the soap dispenser at the time of the outbreak - since
the oncohematology unit was closed due to legal issue,
Table 1 Antibiotic susceptibility in unadapted and triclosan-adapted P.aeruginosa
P. aeruginosa L2 Antibiotic MIC (mg/L)
b
TET CIP AMK LVX CAR CHL
Unadapted 32 16 4 8 128 128
Unadapted plus PAbN (50 μM) 16 4 2 2 64 64
Unadapted plus CCCP (100 μM) 16 8 2 4 64 64
Adapted
a to 3,400 mg/L triclosan 64 32 8 16 256 256
Adapted
a to 3,400 mg/L triclosan plus PAbN (50 μM) 32 8 4 4 64 64
Adapted
a to 3,400 mg/L triclosan plus CCCP (100 μM) 32 16 4 8 64 64
aAdaptation was achieved by serial subculturing in stepwise increasing triclosan concentrations up to 3,400 mg/L triclosan (see Methods). The experimental data
were confirmed by three independent replicates
bBreakpoint criteria were as follows. TET: susceptible, ≤ 4 mg/L; intermediate, 8 mg/L; resistant, ≥ 16 mg/L; CIP: susceptible, ≤ 1 mg/L; intermediate, 2 mg/L;
resistant, ≥ 4 mg/L; AMK: susceptible, ≤ 16 mg/L; resistant, ≥ 32 mg/L; LVX: susceptible, ≤ 2 mg/L; intermediate, 4 mg/L; resistant, ≥ 8 mg/L; CAR: susceptible, ≤
128 mg/L; intermediate, 256 mg/L; resistant, ≥ 512 mg/L; CHL: susceptible, ≤ 8 mg/L; intermediate, 16 mg/L; resistant, ≥ 32 mg/L [12]
MIC minimal inhibitory concentration; PAbN RND pump inhibitor phenyl-arginine-b-naphthylamide; CCCP protonophore carbonyl cyanide m-
chlorophenylhydrazone; TET tetracycline; CIP ciprofloxacin; AMK amikacin; LVX levofloxacin; CAR carbenicillin; CHL chloramphenicol
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chemical analysis. Therefore we cannot rule out that
accidental dilution (below the commercial concentra-
tion) of triclosan soap due to refilling procedure might
have played a preeminent role in facilitating the growth
of P. aeruginosa in the dispenser and the eventual
spreading of the infection. Finally, we only performed
phenotypic assays, and we cannot provide a genetic
basis for the remarkably high resistance to triclosan of
the P. aeruginosa outbreak strain. Intrinsic outer mem-
brane impermeability, resistance of the FabV enoyl-acyl
carrier protein reductase, expression of an additional tri-
closan-specific pump (TriABC-OpmH) or other
unknown mechanisms could have acted synergistically
with efflux in determining the unprecedented triclosan
resistance observed our isolates.
Despite these limitations, this study provide biological
evidence to confirm that an unprecedented environmen-
tal source, which was identified as a triclosan soap dis-
penser, actually acted as a continuous source of
infection during the outbreak. In addition, we provide
hints that exposure to sub-lethal concentration of triclo-
san may contribute to antibiotic resistance in P. aerugi-
nosa clinical isolates.
Conclusions
Since certain strains of P. aeruginosa can grow in the
presence of triclosan concentrations similar to those
present in commercial soap formulations, triclosan-
based disinfectants can incidentally be contaminated
and act as a continuous source of P. aeruginosa in
healthcare settings. The concentration of triclosan-based
disinfectants meant to be used in those facilities admit-
ting patients at high risk for P. aeruginosa infection
should be reassessed.
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